Skip to main content
. 2019 Dec 17;2019:4065327. doi: 10.1155/2019/4065327

Table 2.

The association between the ADRB3 genotype and the risk of NAFLD in the overall study population.

Bivariable Multivariable
OR [95% CI] p value OR [95% CI] p value
ADRB3 rs4994 genotype
 T/T 1 1
 T/C 1.28 [0.84-1.96] 0.26 1.53 [0.91-2.57] 0.11
 C/C 1.95 [0.77-4.93] 0.16 2.31 [0.67-8.01] 0.19
Age 0.98 [0.96-0.99] <0.01 0.97 [0.95-0.99] <0.01
Gender
 Male 1
 Female 0.57 [0.37-0.87] <0.01
BMI 1.55 [1.41-1.71] <0.01 1.42 [1.27-1.58] <0.01
HOMA-IR 2.22 [1.75-2.81] <0.01 1.73 [1.35-2.23] <0.01
Diabetes
 Absent 1
 Present 2.54 [1.52-4.25] <0.01
Dyslipidemia
 Absent 1 1
 Present 4.21 [2.58-6.87] <0.01 3.69 [2.06-6.61] <0.01
Alcohol intake
 Nondrinker 1
 Drinker 0.97 [0.65-1.45] 0.88
Smoking status
 Never smoker 1
 Ever smoker 1.58 [1.05-2.38] 0.03

ADRB3: beta-3-adrenergic receptor; NAFLD: nonalcoholic fatty liver disease; BMI: body mass index; OR: odds ratio; CI: confidence interval. Analyzed using a logistic regression analysis.